New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
Trending
- Elra Kaaleliyatte Kaala Review: A Soulful Ode to Timelessness That Charms Despite Its Flaws
- Sugriva Movie Review (2026): A Gripping Emotional Thriller That Hits Hard
- Licence Review (2026): Masoom Sharma Delivers a Gripping Haryanvi Crime Drama
- Bhagubai (2026) Review: Nirmiti Sawant Shines in This Heartfelt Marathi Village Drama
- Ginny Wedss Sunny 2 Review (2026): A Warm and Relatable Ride Through the Chaos of Arranged Marriage
- Jerax Review (2026): Nagabhushan’s Supernatural Thriller Is a Wildly Entertaining Ride
- Battle (2026) Movie Review — Tamil Rap Drama Finds Its Rhythm in Flashes
- Madhuvidhu Movie Review (2026): Sharaf U Dheen’s Charm Lights Up This Warm Malayalam Rom-Com